Related Experiment Video
Updated: Jun 9, 2025

08:01
Fabrication of Zero Mode Waveguides for High Concentration Single Molecule Microscopy
Published on: May 12, 2020
8.0K
Waveguide-Based Microwave Nitric Oxide Sensor for COVID-19 Screening: Mass Transfer Modulation Effect on Hollow
Renshuo Wang1, Tiangang Ma2, Quan Jin1
1Key Laboratory of Automobile Materials (Ministry of Education), School of Materials Science and Engineering, Jilin University, Changchun 130022, China.
ACS Sensors
|October 23, 2024
Summary
A new hollow multishelled structured WO3 (HoMSs-WO3)-based microwave gas sensor (MGS) detects nitric oxide (NO) in breath for COVID-19 screening. This sensitive and selective sensor shows significant potential for rapid, portable, and non-invasive diagnosis.
Area of Science:
- Materials Science
- Chemical Sensing
- Biomedical Engineering
Background:
- Serious acute respiratory syndrome coronavirus-2 (SARS-CoV-2) presents a global health challenge.
- Volatile organic components in breath are emerging biomarkers for COVID-19 detection.
- Nitric oxide (NO) is a key indicator of respiratory tract inflammation.
Purpose of the Study:
- To develop a novel gas sensor for detecting trace levels of NO in exhaled breath.
- To evaluate the sensor's potential for preliminary COVID-19 diagnosis.
- To assess the sensor's performance characteristics, including sensitivity, selectivity, and limit of detection.
Main Methods:
- Fabrication of a hollow multishelled structured WO3 (HoMSs-WO3)-based waveguide microwave gas sensor (MGS).
- Detection of nitric oxide (NO) in exhaled breath samples.
- Comparison of MGS measurements with a commercial Sunvou detector for clinical samples.
Main Results:
- The HoMSs-WO3 MGS demonstrated high sensitivity (39.27 dB/ppm) and a low detection limit (2.52 ppb) for NO.
- The sensor exhibited excellent reusability and selectivity.
- Measurements from the MGS showed strong correlation with the Sunvou detector for clinical COVID-19 patient breath samples, with a bias within 1.96 standard deviations.
Conclusions:
- The developed HoMSs-WO3 MGS shows significant potential for rapid, portable, and non-invasive COVID-19 screening.
- The sensor's ability to accurately detect NO in exhaled breath supports its use in preliminary diagnosis.
- This technology offers a promising new avenue for epidemiological screening of respiratory diseases.

